每年出版 4 期
ISSN 打印: 0893-9675
ISSN 在线: 2162-6448
Indexed in
Dendritic Cell-Based Vaccines: From Mouse Models to Clinical Cancer Immunotherapy
摘要
B and T lymphocytes are the effectors of specific immunity. However, their function is critically dependent on dendritic cells (DC). DC are professional antigen presenting cells that both initiate and modulate the immune response. The recent breakthrough in the generation of DC from their progenitors has stimulated research on DC in both fundamental and clinical immunology. Objective immune response induction has now been reported in clinical studies using DC. In this review we discuss the development and potential of DC-based vaccines to induce antitumor immunity.
-
Eggert Andreas O., Becker Jürgen C., Ammon Michael, McLellan Alexander D., Renner German, Merkel Angela, Bröcker Eva-B., Kämpgen Eckhart, Specific peptide-mediated immunity against established melanoma tumors with dendritic cells requires IL-2 and fetal calf serum-free cell culture, European Journal of Immunology, 32, 1, 2002. Crossref
-
OSTRAND-ROSENBERG SUZANNE, GILBERT MILEKA, CLEMENTS VIRGINIA K., PULASKI BETH A., DISSANAYAKE SAMUDRA, QI LING, Immunologic Targets for the Gene Therapy of Cancer, in Gene Therapy of Cancer, 2002. Crossref
-
den Brok Martijn HMGM, Nierkens Stefan, Figdor Carl G, Ruers Theo JM, Adema Gosse J, Dendritic cells: tools and targets for antitumor vaccination, Expert Review of Vaccines, 4, 5, 2005. Crossref
-
Zhong Hua, Shurin Michael R, Han Baohui, Optimizing dendritic cell-based immunotherapy for cancer, Expert Review of Vaccines, 6, 3, 2007. Crossref
-
Saha Asim, Bhattacharya-Chatterjee Malaya, Foon Kenneth A., Celis Esteban, Chatterjee Sunil K., Stimulatory effects of CpG oligodeoxynucleotide on dendritic cell-based immunotherapy of colon cancer in CEA/HLA-A2 transgenic mice, International Journal of Cancer, 124, 4, 2009. Crossref
-
Kretz-Rommel Anke, Qin Fenghua, Dakappagari Naveen, Torensma Ruurd, Faas Susan, Wu Dayang, Bowdish Katherine S., In Vivo Targeting of Antigens to Human Dendritic Cells Through DC-SIGN Elicits Stimulatory Immune Responses and Inhibits Tumor Growth in Grafted Mouse Models, Journal of Immunotherapy, 30, 7, 2007. Crossref
-
Do T.H., Johnsen H.E., Kjærsgaard E., Taaning E., Svane I.M., Impaired circulating myeloid DCs from myeloma patients, Cytotherapy, 6, 3, 2004. Crossref
-
Zhang Zhe, Tang Ling-ling, Zhan Ren-ya, Tong Ying, Yao Hang-ping, Du Li-an, Immunotherapy of intracranial G422 glioblastoma with dendritic cells pulsed with tumor extract or RNA, Journal of Zhejiang University-SCIENCE A, 5, 10, 2004. Crossref
-
Gu Jin-Hai, Li Gang, Dendritic cell-based immunotherapy for malignant glioma, Neuroscience Bulletin, 24, 1, 2008. Crossref
-
Rajnavölgyi Éva, Lányi Árpád, , 87, 2003. Crossref
-
Shahum Eliane, Thérien Hélène-Marie, Effect of liposomal antigens on the priming and activation of the immune system by dendritic cells, International Immunopharmacology, 2, 4, 2002. Crossref
-
Jansen Bastiaan J.H., Eleveld-Trancikova Dagmar, Sanecka Anna, van Hout-Kuijer Maaike, Hendriks Ilona A.M., Looman Maaike G.W., Leusen Jeanette H.W., Adema Gosse J., OS9 interacts with DC-STAMP and modulates its intracellular localization in response to TLR ligation, Molecular Immunology, 46, 4, 2009. Crossref
-
Lingnau Karen, Egyed Alena, Schellack Carola, Mattner Frank, Buschle Michael, Schmidt Walter, Poly-l-arginine synergizes with oligodeoxynucleotides containing CpG-motifs (CpG-ODN) for enhanced and prolonged immune responses and prevents the CpG-ODN-induced systemic release of pro-inflammatory cytokines, Vaccine, 20, 29-30, 2002. Crossref
-
Kou Geng, Shi Shu, Wang Hao, Tan Min, Xue Jingya, Zhang Dapeng, Hou Sheng, Qian Weizhu, Wang Shuhui, Dai Jianxin, Li Bohua, Guo Yajun, Preparation and characterization of recombinant protein ScFv(CD11c)-TRP2 for tumor therapy from inclusion bodies in Escherichia coli, Protein Expression and Purification, 52, 1, 2007. Crossref
-
Eggert Andreas A.O., van der Voort Robbert, Torensma Ruurd, Moulin Veronique, Boerman Otto C., Oyen Wim J.G., Punt C.J.A., Diepstra Heleen, de Boer Annemiek J., Figdor Carl G., Adema Gosse J., Analysis of dendritic cell trafficking using EGFP-transgenic mice, Immunology Letters, 89, 1, 2003. Crossref
-
Saha Asim, Chatterjee Sunil K., Dendritic cells pulsed with an anti-idiotype antibody mimicking Her-2/neu induced protective antitumor immunity in two lines of Her-2/neu transgenic mice, Cellular Immunology, 263, 1, 2010. Crossref
-
Tschoep Katharina, Manning Thomas C., Harlin Helena, George Christopher, Johnson Melissa, Gajewski Thomas F., Disparate functions of immature and mature human myeloid dendritic cells: implications for dendritic cell-based vaccines, Journal of Leukocyte Biology, 74, 1, 2003. Crossref
-
Söling Ariane, Rainov Nikolai G., Dendritic Cell Therapy of Primary Brain Tumors, Molecular Medicine, 7, 10, 2001. Crossref
-
Nestle Frank O, Dendritic cell vaccination for cancer therapy, Oncogene, 19, 56, 2000. Crossref
-
den Brok Martijn H. M. G. M., Sutmuller Roger P. M., van der Voort Robbert, Bennink Erik J., Figdor Carl G., Ruers Theo J. M., Adema Gosse J., In Situ Tumor Ablation Creates an Antigen Source for the Generation of Antitumor Immunity, Cancer Research, 64, 11, 2004. Crossref
-
Okano Fumiyoshi, Merad Miriam, Furumoto Katsuyoshi, Engleman Edgar G., In Vivo Manipulation of Dendritic Cells Overcomes Tolerance to Unmodified Tumor-Associated Self Antigens and Induces Potent Antitumor Immunity, The Journal of Immunology, 174, 5, 2005. Crossref